Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Decision Resources: Only half of payers support biosimilar substitution
Drugstore News
Thursday, July 22, 2010 - 9:35am
tags:
biosimilars
Harvard puts tighter limits on medical faculty; restricts involvement with health care industry
Boston.com
Thursday, July 22, 2010 - 9:33am
tags:
Harvard, physician payments
Elan CEO Is Inept, Misleading & Should Go: Investor
Pharmalot
Thursday, July 22, 2010 - 9:30am
tags:
Elan, Pharma CEOs, Kelly Martin
Biotech Stock Mailbag: Ziopharm
TheStreet.com
Thursday, July 22, 2010 - 9:29am
tags:
Ziopharm, MELA Sciences, Vivus
Gilead Holding Up on Exhaustion of Negativity
Seeking Alpha
Thursday, July 22, 2010 - 9:27am
tags:
Gilead Sciences
Cephalon raises 2Q earnings, sales expectations
Yahoo/AP
Thursday, July 22, 2010 - 8:54am
tags:
Cephalon, earnings
Roche Profit Up on Genentech Synergies
NY Times, NY
Thursday, July 22, 2010 - 8:53am
tags:
Roche, earnings, M&A, Genentech
Milestones mitigate risk in biotech deals
Fierce Biotech
Thursday, July 22, 2010 - 8:51am
tags:
biotech, M&A, milestone payments
Endo Pharma Positions Itself For Post-Overhaul Health System
WSJ Online
Thursday, July 22, 2010 - 8:51am
tags:
Endo, healthcare reform
Glaxo To Pay $1B To Settle Paxil Birth Defect Cases
Pharmalot
Thursday, July 22, 2010 - 8:48am
tags:
settlements, Paxil, birth defects, GSK, antidepressants
Bristol-Myers Profit Beats Estimates on Plavix, HIV Treatments
Bloomberg
Thursday, July 22, 2010 - 8:44am
tags:
earnings, Bristol-Myers Squibb
Lilly Boosts Forecast After Topping Analyst Estimates
Bloomberg
Thursday, July 22, 2010 - 8:44am
tags:
Eli Lilly, earnings
15% Revenue Growth Is Good for Pfizer, but Not Gilead
Motley Fool
Thursday, July 22, 2010 - 8:43am
tags:
Pfizer, Gilead Sciences, earnings, JNJ, Bristol-Myers Squibb, Merck
FDA Halts A Controversial Avandia Study
Pharmalot
Wednesday, July 21, 2010 - 4:52pm
tags:
FDA, GSK, Avandia, clinical trials, diabetes
New FDA report shows multiple lapses at J&J plant
Yahoo/AP
Wednesday, July 21, 2010 - 4:51pm
tags:
FDA, recalls, JNJ
FDA Panel Members Talk About Avandia Conflicts
Pharmalot
Wednesday, July 21, 2010 - 3:59pm
tags:
FDA, GSK, Avandia, diabetes, advisory panels
Glaxo takes new AIDS drug into final-stage tests
Reuters
Wednesday, July 21, 2010 - 3:56pm
tags:
AIDS, HIV, GSK, Shionogi
Safety Concerns May Sink Both Vivus and Its Obesity Drug Qnexa
BNET Pharma
Wednesday, July 21, 2010 - 3:55pm
tags:
obesity, Vivus, Qnexa, FDA, Arena Pharmaceuticals, Contrave, Orexigen
Pfizer: Warming Up or Cooling Off?
Motley Fool
Wednesday, July 21, 2010 - 3:54pm
tags:
Pfizer
Genzyme Reports Financial Results for the Second Quarter of 2010
Yahoo
Wednesday, July 21, 2010 - 8:52am
tags:
earnings, Genzyme

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.